ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $3,943,000 | +34.3% | 1,095,359 | 0.0% | 0.03% | +35.0% |
Q2 2019 | $2,936,000 | -9.4% | 1,095,359 | 0.0% | 0.02% | -4.8% |
Q1 2019 | $3,242,000 | +86.1% | 1,095,359 | 0.0% | 0.02% | +50.0% |
Q4 2018 | $1,742,000 | -71.1% | 1,095,359 | -33.2% | 0.01% | -65.0% |
Q3 2018 | $6,035,000 | +9.7% | 1,639,948 | -15.6% | 0.04% | -2.4% |
Q2 2018 | $5,500,000 | -48.1% | 1,943,620 | -32.0% | 0.04% | -54.4% |
Q1 2018 | $10,598,000 | +28.8% | 2,856,637 | 0.0% | 0.09% | +26.8% |
Q4 2017 | $8,227,000 | -1.3% | 2,856,637 | +53.9% | 0.07% | +4.4% |
Q3 2017 | $8,336,000 | -2.2% | 1,856,637 | 0.0% | 0.07% | -9.3% |
Q2 2017 | $8,522,000 | +9.0% | 1,856,637 | 0.0% | 0.08% | +17.2% |
Q1 2017 | $7,816,000 | +1.9% | 1,856,637 | 0.0% | 0.06% | -14.7% |
Q4 2016 | $7,668,000 | -61.8% | 1,856,637 | -25.0% | 0.08% | -58.8% |
Q3 2016 | $20,052,000 | +3.8% | 2,475,515 | 0.0% | 0.18% | -9.9% |
Q2 2016 | $19,309,000 | +1.0% | 2,475,515 | 0.0% | 0.20% | 0.0% |
Q1 2016 | $19,111,000 | -11.4% | 2,475,515 | +23.8% | 0.20% | +12.8% |
Q4 2015 | $21,580,000 | +56.2% | 2,000,000 | 0.0% | 0.18% | +39.8% |
Q3 2015 | $13,820,000 | +2.4% | 2,000,000 | +31.3% | 0.13% | +8.5% |
Q2 2015 | $13,500,000 | +539.2% | 1,523,739 | +611.2% | 0.12% | +555.6% |
Q1 2015 | $2,112,000 | -60.7% | 214,237 | -51.1% | 0.02% | -67.3% |
Q4 2014 | $5,370,000 | +22.7% | 438,337 | 0.0% | 0.06% | 0.0% |
Q3 2014 | $4,375,000 | +31.9% | 438,337 | 0.0% | 0.06% | +34.1% |
Q2 2014 | $3,318,000 | +130.1% | 438,337 | 0.0% | 0.04% | +127.8% |
Q1 2014 | $1,442,000 | -4.5% | 438,337 | -3.7% | 0.02% | -14.3% |
Q4 2013 | $1,510,000 | +9.9% | 455,000 | 0.0% | 0.02% | +5.0% |
Q3 2013 | $1,374,000 | -63.1% | 455,000 | 0.0% | 0.02% | -73.0% |
Q2 2013 | $3,722,000 | – | 455,000 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|